An mRNA assay system demonstrates proteasomal-specific degradation contributes to cardiomyopathic phospholamban null mutation.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Eduarde Rohner; Nevin Witman; Jesper Sohlmer; Erwin De Genst; William E. Louch; William E. Louch; Makoto Sahara; Makoto Sahara; Kenneth R. Chien

Journal title: Molecular Medicine

Journal number: 27

Journal publisher: Springer Nature

Published year: 2021

Published pages: 102

DOI identifier: 10.1186/s10020-021-00362-8

ISSN: 1528-3658